PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Faculty of Medicine of Campos dos Goytacazes, Av. Alberto Torres, 217, Campos dos Goytacazes, Brazil.\', \'Department of Pharmacology, Federal University of the State of Rio de Janeiro, Rio de Janeiro, Brazil.\', \'Molecular Biology Laboratory, Biomedical Research Institute, MarcĂ­lio Dias Navy Hospital, Rio de Janeiro, Brazil.\', \'Department of Pharmacology, Institute of Biology, Rio de Janeiro State University, Rio de Janeiro, Brazil.\', \'Faculty of Medicine of Campos dos Goytacazes, Av. Alberto Torres, 217, Campos dos Goytacazes, Brazil. daniel.jose@fmc.br.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s43440-021-00286-4
?:doi
?:hasPublicationType
?:journal
  • Pharmacological reports : PR
is ?:pmid of
?:pmid
?:pmid
  • 34085181
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Use of glucocorticoids and azithromycin in the therapy of COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all